World's Best Scientists 2026 revealed!
Jerrold F. Rosenbaum

Jerrold F. Rosenbaum

D-Index & Metrics

Medicine

D-Index
116
Citations
50013
World Ranking
4350
National Ranking
2372

Overview

Jerrold F. Rosenbaum is affiliated with Harvard University in the United States. Their research spans multiple domains within psychology and medicine, focusing particularly on experimental and cognitive psychology as well as psychiatry and mental health. Their work includes contributions to clinical psychology, cognitive neuroscience, and pharmacology.

Their scientific publications cover a range of topics, including child and adolescent psychosocial and emotional development, attention deficit hyperactivity disorder, cognitive abilities and testing, anxiety, depression, psychometrics, treatment, cognitive processes, mental health research topics, treatment of major depression, and sleep and related disorders.

Frequent coauthors in their research include Dina R. Hirshfeld-Becker, Joseph Biederman, Maurizio Fava, Mai Uchida, and Maura DiSalvo. These collaborations have resulted in various papers published across several venues.

Key recent papers authored or coauthored by Jerrold F. Rosenbaum include:

  • A Survey of Prescribing Preferences in the Treatment of Refractory Depression: Recent Trends, 2025, Psychopharmacology Bulletin
  • Benzodiazepines: A Perspective, 2020, American Journal of Psychiatry
  • Further Evidence that Subsyndromal Manifestations of Depression in Childhood Predict the Subsequent Development of Major Depression: A Replication Study in a 10 Year Longitudinally Assessed Sample, 2021, Journal of Affective Disorders
  • Cognitive-Behavioral Strategies to Manage Panic Disorder, 2021, Psychiatric Annals
  • Functional Unblinding in Pivotal Studies and the Future of Psychedelic Medicine, 2024, PubMed

Publication venues frequently featuring their work include Journal of Affective Disorders, Psychiatric Annals, PubMed, Psychopharmacology Bulletin, and American Journal of Psychiatry.

Best Publications

  • Acute and Longer- Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

    A. John Rush;Madhukar H. Trivedi;Stephen R. Wisniewski;Andrew A. Nierenberg

  • PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder

    Alan J. Gelenberg;P. Freeman;John C. Markowitz;Jerrold F. Rosenbaum

  • Sequenced treatment alternatives to relieve depression (STAR * D): rationale and design

    A.John Rush;Maurizio Fava;Stephen R Wisniewski;Philip W Lavori

  • Further evidence of association between behavioral inhibition and social anxiety in children.

    Joseph Biederman;Dina R. Hirshfeld-Becker;Jerrold F. Rosenbaum;Christine Hérot

  • Report by the ACNP Task Force on Response and Remission in Major Depressive Disorder

    A John Rush;Helena C Kraemer;Harold A Sackeim;Maurizio Fava

  • Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.

    Jerrold F Rosenbaum;Maurizio Fava;Sharon L Hoog;Richard C Ascroft

  • Stable behavioral inhibition and its association with anxiety disorder.

    Dina R. Hirshfeld;Jerrold F. Rosenbaum;Joseph Biederman;Elizabeth A. Bolduc

  • A 3-Year Follow-up of Children with and without Behavioral Inhibition

    Joseph Biederman;Jerrold F. Rosenbaum;Elizabeth A. Bolduc-Murphy;Stephen V. Faraone

  • Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study.

    Maurizio Fava;A. John Rush;Madhukar H. Trivedi;Andrew A. Nierenberg

  • Psychiatric Correlates of Behavioral Inhibition in Young Children of Parents With and Without Psychiatric Disorders

    Joseph Biederman;Jerrold F. Rosenbaum;Dina R. Hirshfeld;Stephen V. Faraone

  • Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

    Gary S Sachs;Michael E Thase;Michael W Otto;Mark Bauer

  • Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder

    AJ Gelenberg;JM Kane;MB Keller;P Lavori

  • Residual symptoms in depressed patients who respond acutely to fluoxetine.

    Andrew A. Nierenberg;Bronwyn R. Keefe;Vinita C. Leslie;Jonathan E. Alpert

  • Anxiety disorders in major depression

    Maurizio Fava;Meridith A. Rankin;Emma C. Wright;Jonathan E. Alpert

  • Folate, vitamin B12, and homocysteine in major depressive disorder.

    Maurizio Fava;Joseph S. Borus;Jonathan E. Alpert;Andrew A. Nierenberg

  • A double-blind trial of bupropion versus desipramine for bipolar depression.

    Gary S. Sachs;Beny Lafer;Andrew L. Stoll;Michael Banov

  • Behavioral Inhibition in Children of Parents With Panic Disorder and Agoraphobia: A Controlled Study

    Jerrold F. Rosenbaum;Joseph Biederman;Michelle Gersten;Dina R. Hirshfeld

  • Patterns of psychopathology and dysfunction in high-risk children of parents with panic disorder and major depression.

    Joseph Biederman;Stephen V. Faraone;Dina R. Hirshfeld-Becker;Deborah Friedman

  • Behavioral Inhibition in Childhood: A Risk Factor for Anxiety Disorders

    Jerrold F. Rosenbaum;Joseph Biederman;Elizabeth A. Bolduc-Murphy;Stephen V. Faraone

  • Anger attacks in unipolar depression. I: Clinical correlates and response to fluoxetine treatment

    Maurizio Fava;Jerrold F. Rosenbaum;Joel A. Pava;Mary K. McCarthy

Frequent Co-Authors

Maurizio Fava
Maurizio Fava Harvard University
Mark H. Pollack
Mark H. Pollack Rush University Medical Center
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Jonathan E. Alpert
Jonathan E. Alpert Harvard University
Dina R. Hirshfeld-Becker
Dina R. Hirshfeld-Becker Harvard University
Gary S. Sachs
Gary S. Sachs Harvard University
Lee S. Cohen
Lee S. Cohen Harvard University
Jay D. Amsterdam
Jay D. Amsterdam University of Pennsylvania
Aude Henin
Aude Henin Harvard University
David Mischoulon
David Mischoulon Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring the field of medicine in the USA opens up a variety of rewarding career paths—even beyond traditional MD programs. For current RNs looking to advance their education, rn to bsn online programs offer a flexible and affordable way to earn a bachelor's degree while working.

Individuals with non-nursing backgrounds who aspire to enter the nursing profession may consider direct entry msn programs for non-nursing majors online. These programs let graduates transition quickly into advanced nursing roles without starting from scratch.

If you're seeking a faster or more accessible route into nursing, online adn programs could be an excellent starting point. These Associate Degree in Nursing (ADN) tracks are known for fewer barriers to entry and can quickly prepare you for RN licensure.

For those interested in a vital, non-clinical healthcare career, medical billing and coding schools online with financial aid provide training that leads to in-demand roles supporting the business and administrative side of medicine.

Best Scientists Citing Jerrold F. Rosenbaum

Trending Scientists

Recently Published Articles